Clinical Trial

Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection

Name: Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection — clinical trial record (NCT07536282)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a two-part, phase I/IIa study, intended to evaluate the safety, tolerability, immunogenicity, and efficacy of NWRD09 in female participants with persistent HPV16 infection, and to determine the MTD, and/or RP2D of NWRD09.

Trial Details

NCT Number	NCT07536282
Lead Sponsor	Newish Biotech (Wuxi) Co., Ltd.
Conditions	Persistent HPV16 Infection
Enrollment	78 participants
Start Date	2026-10
Primary Completion	2027-09 (estimated)
Study Completion	2027-11 (estimated)
Updated on ClinicalTrials.gov	2026-04-17